Renaissance Technologies - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 164 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$617
-100.0%
16,554
-86.2%
0.00%
-85.7%
Q2 2022$6,190,000
+618.1%
119,600
+191.7%
0.01%
+600.0%
Q2 2020$862,000
+60.2%
41,000
+11.7%
0.00%
Q4 2019$538,000
-80.0%
36,700
-77.7%
0.00%
-100.0%
Q2 2019$2,695,000
-13.4%
164,600
-27.8%
0.00%
-33.3%
Q4 2018$3,112,000
+913.7%
228,000
+1087.5%
0.00%
Q2 2017$307,00019,2000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders